Trials / Sponsors / AceLink Therapeutics, Inc.
AceLink Therapeutics, Inc.
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of the Safety and Biologic Activity of AL01211 in Treatment Naive Males With Classic Fabry Disease Fabry Disease | Phase 2 | 2023-10-25 |
| Completed | To Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AL01211 in Healthy Volunte Autosomal Dominant Polycystic Kidney | Phase 1 | 2021-06-08 |